Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

477.60
+14.183.06%
Post-market: 477.600.00000.00%18:59 EST
Volume:338.62K
Turnover:161.27M
Market Cap:10.85B
PE:-36.64
High:482.88
Open:475.69
Low:465.20
Close:463.42
52wk High:615.00
52wk Low:265.00
Shares:22.71M
Float Shares:11.00M
Volume Ratio:0.85
T/O Rate:3.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0355
EPS(LYR):-21.9007
ROE:-41.22%
ROA:-15.78%
PB:17.33
PE(LYR):-21.81

Loading ...

Madrigal Pharmaceuticals Grants Equity Awards to New Employees

Reuters
·
Yesterday

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule

Reuters
·
Yesterday

Does Madrigal Pharmaceuticals (MDGL) Offer Value After Recent Share Price Weakness

Simply Wall St.
·
Feb 05

Madrigal Pharmaceuticals Inc. to Release Fourth-Quarter and Full-Year 2025 Financial Results

Reuters
·
Feb 02

Madrigal Builds Commercial Bench With Equity Grants Around Rezdiffra Growth Story

Simply Wall St.
·
Feb 02

Madrigal Pharmaceuticals Inc - and Roche Enter Into First Amendment to Agreement - SEC Filing

THOMSON REUTERS
·
Jan 31

Madrigal Pharmaceuticals Inc - Co Gains Control Over Rezdiffra Patent Term Adjustments - SEC Filing

THOMSON REUTERS
·
Jan 31

Madrigal Pharmaceuticals Gains Patent Control for Rezdiffra in Amended Roche Agreement

Reuters
·
Jan 31

Rezdiffra Sales Milestone and Pfizer DGAT-2 Deal Might Change The Case For Investing In Madrigal Pharmaceuticals (MDGL)

Simply Wall St.
·
Jan 29

Biotech Inventiva's 50% surge shows investor optimism over liver disease drug

Reuters
·
Jan 28

Madrigal Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Madrigal Pharmaceuticals initiated with an Overweight at Barclays

TIPRANKS
·
Jan 28

Madrigal Pharmaceuticals Lobbying And Insider Sales Put Valuation In Focus

Simply Wall St.
·
Jan 27

Can Trump and Big Pharma Get the World to Pay More for Drugs? -- Heard on the Street -- WSJ

Dow Jones
·
Jan 25

BRIEF-Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jan 23

Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer License For Ervogastat In MASH Therapy Combinations

Simply Wall St.
·
Jan 23

Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jan 22

U.S. RESEARCH ROUNDUP-Datadog, IBM, Netflix

Reuters
·
Jan 21

Top Madrigal Pharmaceuticals Insiders Quietly Cash In On Shares

TIPRANKS
·
Jan 21

Madrigal Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Rita Thakkar

Reuters
·
Jan 21